Thus, a change in the balance of T cell osteoclastogenic activity, arising from the reduced annexin A1 mRNA levels in PBMCs from osteopenia/osteoporosis patients, could contribute to their osteopenia/osteoporosis. This evidence concerns the gene ANXA1 and Osteopenia.